Zoetis Inc. (ZTS)

NYSE • Currently down 104.09 (-57.54%) in today's trading session

15 members of Congress have disclosed 55 trades in Zoetis Inc. (ZTS) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 16 June 2026. The most active traders have been Jefferson Shreve (8), John Curtis (8), and Dan Sullivan (8). Aggregate disclosed activity totals roughly $314.5K in purchases and $290K in sales (midpoint estimates from bracketed disclosure amounts).

Zoetis Inc. is currently trading at $76.81, positioned at 7% of its 52-week range ($71.00 – $157.21).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$76.81
24h Change
-104.09 (-57.54%)
52 Week Range
$71.00—$157.21
View on NASDAQ

Zoetis Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ZTS

Select to highlight on chart
37 transactions
Compliance: 67%
Gilbert Cisneros16 Jun 20262 Jul 2026PurchaseStock$1,001 - $15,000-3.93%
Byron Donalds9 Jun 202615 Jul 2026PurchaseStock$1,001 - $15,000-2.55%
Byron Donalds9 Jun 202615 Jul 2026PurchaseStock$1,001 - $15,000-2.55%
Charles J. "Chuck" Fleischmann9 Jun 20268 Jul 2026PurchaseStock$15,001 - $50,000-2.55%
Gilbert Cisneros14 Apr 20268 May 2026SaleStock$1,001 - $15,000N/A
Gilbert Cisneros13 Mar 20267 Apr 2026SaleStock$1,001 - $15,000N/A
Gilbert Cisneros10 Feb 20269 Mar 2026PurchaseStock$1,001 - $15,000-39.66%
Gilbert Cisneros19 Dec 202512 Jan 2026PurchaseStock$1,001 - $15,000-37.43%
Gilbert Cisneros18 Nov 202515 Dec 2025PurchaseStock$1,001 - $15,000-35.35%
Rick Larsen6 Oct 202516 Oct 2025SaleStock$1,001 - $15,000N/A
Gilbert Cisneros5 Aug 202512 Sept 2025SaleStock$1,001 - $15,000N/A
Lisa McClain4 Aug 202512 Sept 2025SaleStock$1,001 - $15,000N/A
Lisa McClain22 Jul 202513 Aug 2025PurchaseStock$1,001 - $15,000N/A
Robert P. Bresnahan15 May 202531 May 2025PurchaseStock$1,001 - $15,000N/A
Jefferson Shreve12 May 202522 Jun 2025SaleStock$15,001 - $50,000N/A
Jefferson Shreve17 Apr 20258 May 2025SaleStock$15,001 - $50,000N/A
Robert P. Bresnahan8 Apr 202528 Apr 2025SaleStock$1,001 - $15,000N/A
Jefferson Shreve7 Apr 20258 May 2025PurchaseStock$15,001 - $50,000N/A
Julie Johnson1 Apr 202514 May 2025SaleStock$1,001 - $15,000N/A
Greg Landsman27 Mar 20258 Apr 2025SaleStock$1,001 - $15,000N/A
Jefferson Shreve5 Mar 202511 Apr 2025PurchaseStock$15,001 - $50,000N/A
Julie Johnson3 Mar 202514 Apr 2025SaleStock$1,001 - $15,000N/A
Robert P. Bresnahan25 Feb 202527 Mar 2025SaleStock$1,001 - $15,000N/A
Jared Moskowitz5 Jul 20246 Aug 2024SaleStock$1,001 - $15,000N/A
Jared Moskowitz5 Jul 20246 Aug 2024SaleStock$1,001 - $15,000N/A
Jared Moskowitz5 Jul 202419 Aug 2024SaleStock$1,001 - $15,000N/A
Shelley Moore Capito27 Feb 202415 Mar 2024Stock$15,001 - $50,000N/A
John Curtis4 Dec 202315 Dec 2023SaleStock$1,001 - $15,000N/A
Dan Sullivan22 Aug 202318 Sept 2023SaleStock$1,001 - $15,000N/A
Dan Sullivan22 Aug 202322 Sept 2023SaleStock$1,001 - $15,000N/A
Dan Sullivan10 Jan 202313 Feb 2023Stock$1,001 - $15,000N/A
John Curtis20 Dec 202210 Jan 2023PurchaseStock$1,001 - $15,000N/A
Dan Sullivan30 Nov 202221 Dec 2022Stock$1,001 - $15,000N/A
John Curtis28 Jun 20228 Jul 2022PurchaseStock$1,001 - $15,000N/A
Dan Newhouse8 Mar 202226 May 2023PurchaseStock$1,001 - $15,000N/A
John Curtis27 Mar 20209 Apr 2020PurchaseStock$1,001 - $15,000N/A
Susie Lee25 Apr 20199 May 2019SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$32.2B

Volume

1.38M

Beta

0.73

P/E Ratio

11.67

Fundamentals

EPS

$6.58

Div. Yield

2.72%

Open

$77.59

Day Range

$76.67 — $78.20

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE · USD
Country
US
CEO
Kristin C. Peck
IPO Date
2013-02-01
Website
www.zoetis.com

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of...

Earnings

Next Report

Q3 2026

3 Nov

EPS Est.

$1.53

Rev. Est.

$2.3B

Days Until

71

Recent Quarters

Q2 20266 Aug
EPS$1.87
Beat 1.1%
Q1 20267 May
EPS$1.53
Miss 4.4%
Q4 202512 Feb
EPS$1.48
Beat 5.7%
Q3 20254 Nov
EPS$1.70
Beat 4.9%
Q2 20255 Aug
EPS$1.76
Beat 8.6%
Q1 20256 May
EPS$1.48
Beat 5.0%
Q4 202413 Feb
EPS$1.40
Beat 2.2%
Q3 20244 Nov
EPS$1.58
Beat 8.2%
Q2 20246 Aug
EPS$1.56
Beat 4.7%
Q1 20242 May
EPS$1.38
Beat 3.0%
Q4 202313 Feb
EPS$1.24
Miss 6.1%
Q3 20232 Nov
EPS$1.36
Beat 0.0%
Q2 20238 Aug
EPS$1.41
Beat 6.8%
Q1 20234 May
EPS$1.31
Beat 4.0%
Q4 202214 Feb
EPS$1.15
Beat 9.5%
Q3 20223 Nov
EPS$1.21
Miss 2.4%
Q2 20224 Aug
EPS$1.20
Miss 1.6%
Q1 20225 May
EPS$1.32
Beat 7.3%
Q4 202115 Feb
EPS$1.00
Beat 4.2%
Q3 20214 Nov
EPS$1.25
Beat 13.6%
Q2 20215 Aug
EPS$1.19
Beat 10.2%
Q1 20216 May
EPS$1.26
Beat 22.3%
Q4 202016 Feb
EPS$0.91
Beat 4.6%
Q3 20205 Nov
EPS$1.10
Beat 19.6%
Q2 20206 Aug
EPS$0.89
Beat 39.1%
Q1 20206 May
EPS$0.95
Beat 10.5%
Q4 201913 Feb
EPS$0.92
Beat 4.5%
Q3 20197 Nov
EPS$0.94
Beat 6.8%
Q2 20196 Aug
EPS$0.90
Beat 9.8%
Q1 20192 May
EPS$0.88
Beat 11.4%
Q4 201814 Feb
EPS$0.79
Beat 2.6%
Q3 20181 Nov
EPS$0.83
Beat 7.8%
Q2 20182 Aug
EPS$0.77
Beat 10.0%
Q1 20182 May
EPS$0.75
Beat 8.7%
Q4 201715 Feb
EPS$0.69
Beat 4.5%
Q3 20172 Nov
EPS$0.65
Beat 4.8%
Q2 20178 Aug
EPS$0.53
Beat 0.0%
Q1 20174 May
EPS$0.53
Beat 10.4%
Q4 201616 Feb
EPS$0.47
Beat 4.4%
Q3 20162 Nov
EPS$0.52
Beat 13.0%
Q2 20163 Aug
EPS$0.49
Beat 11.4%
Q1 20164 May
EPS$0.48
Beat 17.1%
Q4 201516 Feb
EPS$0.43
Beat 10.3%
Q3 20153 Nov
EPS$0.50
Beat 25.0%
Q2 20154 Aug
EPS$0.43
Beat 13.2%
Q1 20155 May
EPS$0.41
Beat 10.8%
Q4 201411 Feb
EPS$0.40
Beat 11.1%
Q3 20144 Nov
EPS$0.41
Beat 10.8%
Q2 20145 Aug
EPS$0.38
Miss 2.6%
Q1 20146 May
EPS$0.38
Beat 2.7%
Q4 201311 Feb
EPS$0.36
Beat 2.9%
Q3 20135 Nov
EPS$0.34
Miss 2.9%
Q2 20136 Aug
EPS$0.36
Beat 0.0%
Q1 201330 Apr
EPS$0.36
Beat 9.1%
Q4 201228 Mar
EPS$-0.02
Q4 201227 Mar
EPS$0.11
Miss 59.3%
Q1 201230 Jun
EPS$0.36
Q4 201131 Mar
EPS$0.23
Q3 201131 Dec
EPS$0.02
Q2 201130 Sept
EPS$0.19
Q1 201130 Jun
EPS$0.13
Q4 201031 Mar
EPS$0.16

11 politicians traded within 30 days

Dividends

Dividend History

20 Jul 2026
Amount $0.5300
20 Apr 2026
Amount $0.5300
20 Jan 2026
Amount $0.5300
31 Oct 2025
Amount $0.5000
18 Jul 2025
Amount $0.5000
21 Apr 2025
Amount $0.5000
21 Jan 2025
Amount $0.5000
31 Oct 2024
Amount $0.4320
18 Jul 2024
Amount $0.4320
18 Apr 2024
Amount $0.4320
18 Jan 2024
Amount $0.4320
31 Oct 2023
Amount $0.3750
20 Jul 2023
Amount $0.3750
20 Apr 2023
Amount $0.3750
19 Jan 2023
Amount $0.3750
31 Oct 2022
Amount $0.3250
20 Jul 2022
Amount $0.3250
20 Apr 2022
Amount $0.3250
19 Jan 2022
Amount $0.3250
28 Oct 2021
Amount $0.2500
20 Jul 2021
Amount $0.2500
20 Apr 2021
Amount $0.2500
19 Jan 2021
Amount $0.2500
20 Oct 2020
Amount $0.2000
16 Jul 2020
Amount $0.2000
16 Apr 2020
Amount $0.2000
16 Jan 2020
Amount $0.2000
21 Oct 2019
Amount $0.1640
18 Jul 2019
Amount $0.1640
17 Apr 2019
Amount $0.1640
17 Jan 2019
Amount $0.1640
19 Nov 2018
Amount $0.1260
19 Jul 2018
Amount $0.1260
19 Apr 2018
Amount $0.1260
18 Jan 2018
Amount $0.1260
8 Nov 2017
Amount $0.1050
13 Jun 2017
Amount $0.1050
4 Apr 2017
Amount $0.1050
18 Jan 2017
Amount $0.1050
1 Nov 2016
Amount $0.0950
28 Jun 2016
Amount $0.0950
5 Apr 2016
Amount $0.0950
19 Jan 2016
Amount $0.0950
3 Nov 2015
Amount $0.0830
11 Aug 2015
Amount $0.0830
7 Apr 2015
Amount $0.0830
20 Jan 2015
Amount $0.0830
3 Nov 2014
Amount $0.0720
18 Aug 2014
Amount $0.0720
24 Apr 2014
Amount $0.0720
28 Jan 2014
Amount $0.0720
30 Oct 2013
Amount $0.0650
30 Jul 2013
Amount $0.0650
29 Apr 2013
Amount $0.0650

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

70
$1245.68-9.72 (-0.77%)
Healthcare
4 politicians hold this stock
Same sector: Healthcare
4 politicians
View Stock

JNJ

Johnson & Johnson

60
$273.48+3.24 (+1.20%)
Healthcare
3 politicians hold this stock
Same sector: Healthcare
3 politicians
View Stock

NVDA

NVIDIA Corporation

43
$209.75-4.97 (-2.31%)
Technology
4 politicians hold this stock
Significant holdings value
4 politicians
View Stock

Frequently Asked Questions about ZTS

Which members of Congress have traded ZTS?
15 members of Congress have disclosed 55 trades in Zoetis Inc. (ZTS) under the STOCK Act. The most active traders are Jefferson Shreve, John Curtis, and Dan Sullivan.
When was ZTS most recently disclosed by Congress?
The most recent ZTS disclosure was a purchase by Gilbert Cisneros on 16 June 2026.
What is the total disclosed congressional trading volume for ZTS?
Members of Congress have disclosed approximately $314.5K in ZTS purchases and $290K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ZTS?
This ZTS page updates as soon as new STOCK Act disclosures are filed for Zoetis Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.